{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:27:15Z","timestamp":1780093635512,"version":"3.54.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T00:00:00Z","timestamp":1504742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1038\/aps.2017.91","type":"journal-article","created":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T13:41:26Z","timestamp":1504791686000},"page":"405-414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["GOLPH2-regulated oncolytic adenovirus, GD55, exerts strong killing effect on human prostate cancer stem-like cells in vitro and in vivo"],"prefix":"10.1038","volume":"39","author":[{"given":"Chang","family":"Ying","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-duan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-mei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,7]]},"reference":[{"key":"BFaps201791_CR1","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1002\/cncr.25899","volume":"117","author":"JM Holzbeierlein","year":"2011","unstructured":"Holzbeierlein JM . Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer. Cancer 2011; 117: 2830\u20132.","journal-title":"Cancer"},{"key":"BFaps201791_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ncomms1159","volume":"2","author":"VK Rajasekhar","year":"2011","unstructured":"Rajasekhar VK, Studer L, Gerald W, Socci ND, Scher HI . Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling. Nat Commun 2011; 2: 162.","journal-title":"Nat Commun"},{"key":"BFaps201791_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","volume":"21","author":"JA Magee","year":"2012","unstructured":"Magee JA, Piskounova E, Morrison SJ . Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 2012; 21: 283\u201396.","journal-title":"Cancer Cell"},{"key":"BFaps201791_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","volume":"10","author":"JE Visvader","year":"2012","unstructured":"Visvader JE, Lindeman GJ . Cancer stem cells: current status and evolving complexities. Cell Stem Cell 2012; 10: 717\u201328.","journal-title":"Cell Stem Cell"},{"key":"BFaps201791_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature12624","volume":"501","author":"CE Meacham","year":"2013","unstructured":"Meacham CE, Morrison SJ . Tumour heterogeneity and cancer cell plasticity. Nature 2013; 501: 328\u201337.","journal-title":"Nature"},{"key":"BFaps201791_CR6","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nature07427","volume":"456","author":"KG Leong","year":"2008","unstructured":"Leong KG, Wang BE, Johnson L, Gao WQ . Generation of a prostate from a single adult stem cell. Nature 2008; 456: 804\u20138.","journal-title":"Nature"},{"key":"BFaps201791_CR7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/j.1349-7006.2009.01110.x","volume":"100","author":"DB Yu","year":"2009","unstructured":"Yu DB, Zhong SY, Yang M, Wang YG, Qian QJ, Zheng S, et al. Potent antitumor activity of double-regulated oncolytic adenovirus-mediated ST13 for colorectal cancer. Cancer Sci 2009; 100: 678\u201383.","journal-title":"Cancer Sci"},{"key":"BFaps201791_CR8","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1089\/hum.2008.205","volume":"20","author":"KJ Zhang","year":"2009","unstructured":"Zhang KJ, Wang YG, Cao X, Zhong SY, Wei RC, Wu YM, et al. Potent antitumor effect of interleukin-24 gene in the survivin promoter and retinoblastoma double-regulated oncolytic adenovirus. Hum Gene Ther 2009; 20: 818\u201330.","journal-title":"Hum Gene Ther"},{"key":"BFaps201791_CR9","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/mt.2009.193","volume":"17","author":"TP Cripe","year":"2009","unstructured":"Cripe TP, Wang PY, Marcato P, Mahller YY, Lee PW . Targeting cancer-initiating cells with oncolytic viruses. Mol Ther 2009; 17: 1677\u201382.","journal-title":"Mol Ther"},{"key":"BFaps201791_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean M, Fojo T, Bates S . Tumour stem cells and drug resistance. Nat Rev Cancer 2005; 5: 275\u201384.","journal-title":"Nat Rev Cancer"},{"key":"BFaps201791_CR11","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/jcmm.12397","volume":"19","author":"Y Yang","year":"2015","unstructured":"Yang Y, Xu H, Huang W, Ding M, Xiao J, Yang D, et al. Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus. J Cell Mol Med 2015; 19: 915\u201323.","journal-title":"J Cell Mol Med"},{"key":"BFaps201791_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/hum.2005.16.845","volume":"16","author":"L Zhao","year":"2005","unstructured":"Zhao L, Gu J, Dong A, Zhang Y, Zhong L, He L, et al. Potent antitumor activity of oncolytic adenovirus expressing mda-7\/IL-24 for colorectal cancer. Hum Gene Ther 2005; 16: 845\u201358.","journal-title":"Hum Gene Ther"},{"key":"BFaps201791_CR13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/sj.cr.7310088","volume":"16","author":"XY Liu","year":"2006","unstructured":"Liu XY, Gu JF . Targeting gene-virotherapy of cancer. Cell Res 2006; 16: 740.","journal-title":"Cell Res"},{"key":"BFaps201791_CR14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/sj.cr.7290191","volume":"13","author":"ZL Zhang","year":"2003","unstructured":"Zhang ZL, Zou WG, Luo CX, Li BH, Wang JH, Sun LY, et al. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy. Cell Res 2003; 13: 481\u20139.","journal-title":"Cell Res"},{"key":"BFaps201791_CR15","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1158\/0008-5472.CAN-05-1834","volume":"66","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Gu J, Zhao L, He L, Qian W, Wang J, et al. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy. Cancer Res 2006; 66: 4291\u20138.","journal-title":"Cancer Res"},{"key":"BFaps201791_CR16","doi-asserted-by":"crossref","first-page":"13564","DOI":"10.18632\/oncotarget.3769","volume":"6","author":"Y Wang","year":"2015","unstructured":"Wang Y, Liu T, Huang P, Zhao H, Zhang R, Ma B, et al. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma. Oncotarget 2015; 6: 13564\u201378.","journal-title":"Oncotarget"},{"key":"BFaps201791_CR17","doi-asserted-by":"crossref","first-page":"29346","DOI":"10.18632\/oncotarget.8830","volume":"7","author":"X Zhang","year":"2016","unstructured":"Zhang X, Meng S, Zhang R, Ma B, Liu T, Yang Y, et al. GP73-regulated oncolytic adenoviruses possess potent killing effect on human liver cancer stem-like cells. Oncotarget 2016; 7: 29346\u201358.","journal-title":"Oncotarget"},{"key":"BFaps201791_CR18","first-page":"128","volume":"14","author":"Y Yang","year":"2015","unstructured":"Yang Y, Xu H, Shen J, Wu S, Xiao J, Xu Y, et al. RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells. Cell Death Dis 2015; 14: 128.","journal-title":"Cell Death Dis"},{"key":"BFaps201791_CR19","doi-asserted-by":"publisher","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","volume":"65","author":"AT Collins","year":"2005","unstructured":"Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ . Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65: 10946\u201351.","journal-title":"Cancer Res"},{"key":"BFaps201791_CR20","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00018-012-1160-9","volume":"70","author":"A Collura","year":"2013","unstructured":"Collura A, Marisa L, Trojan D, Buhard O, Lagrange A, Saget A, et al. Extensive characterization of sphere models established from colorectal cancer cell lines. Cell Mol Life Sci 2013; 70: 729\u201342.","journal-title":"Cell Mol Life Sci"},{"key":"BFaps201791_CR21","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821\u20138.","journal-title":"Cancer Res"},{"key":"BFaps201791_CR22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1371\/annotation\/6b155146-de73-4733-83b0-62224d84717e","volume":"8","author":"BS Ding","year":"2013","unstructured":"Ding BS, James D, Iyer R, Falciatori I, Hambardzumyan D, Wang S, et al. Prominin 1\/CD133 endothelium sustains growth of proneural glioma. PLoS One 2013; 8: 1093\u20137.","journal-title":"PLoS One"},{"key":"BFaps201791_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/pros.21239","volume":"71","author":"E Missol-Kolka","year":"2011","unstructured":"Missol-Kolka E, Karbanova J, Janich P, Haase M, Fargeas CA, Huttner WB, et al. Prominin-1 (CD133) is not restricted to stem cells located in the basal compartment of murine and human prostate. Prostate 2011; 71: 254\u201367.","journal-title":"Prostate"},{"key":"BFaps201791_CR24","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/sj.bjc.6604242","volume":"98","author":"EM Hurt","year":"2008","unstructured":"Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL . CD44+ CD24(-) prostate cells are early cancer progenitor\/stem cells that provide a model for patients with poor prognosis. Br J Cancer 2008; 98: 756\u201365.","journal-title":"Br J Cancer"},{"key":"BFaps201791_CR25","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/sj.onc.1209327","volume":"25","author":"L Patrawala","year":"2006","unstructured":"Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006; 25: 1696\u2013708.","journal-title":"Oncogene"},{"key":"BFaps201791_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.7150\/ijbs.5855","volume":"9","author":"L Wang","year":"2013","unstructured":"Wang L, Huang X, Zheng X, Wang X, Li S, Zhang L, et al. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy. Int J Biol Sci 2013; 9: 472\u20139.","journal-title":"Int J Biol Sci"},{"key":"BFaps201791_CR27","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1158\/0008-5472.CAN-06-4608","volume":"67","author":"G Gu","year":"2007","unstructured":"Gu G, Yuan J, Wills M, Kasper S . Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 2007; 67: 4807\u201315.","journal-title":"Cancer Res"},{"key":"BFaps201791_CR28","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/stem.29","volume":"27","author":"CR Jeter","year":"2009","unstructured":"Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C, et al. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 2009; 27: 993\u20131005.","journal-title":"Stem Cells"},{"key":"BFaps201791_CR29","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1038\/onc.2011.114","volume":"30","author":"CR Jeter","year":"2011","unstructured":"Jeter CR, Liu B, Liu X, Chen X, Liu C, Calhoun-Davis T, et al. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 2011; 30: 3833\u201345.","journal-title":"Oncogene"},{"key":"BFaps201791_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/pros.21217","volume":"71","author":"AV Ugolkov","year":"2011","unstructured":"Ugolkov AV, Eisengart LJ, Luan C, Yang XJ . Expression analysis of putative stem cell markers in human benign and malignant prostate. Prostate 2011; 71: 18\u201325.","journal-title":"Prostate"},{"key":"BFaps201791_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1073\/pnas.0810956106","volume":"106","author":"A Dubrovska","year":"2009","unstructured":"Dubrovska A, Kim S, Salamone RJ, Walker JR, Maira SM, Garcia-Echeverria C, et al. The role of PTEN\/Akt\/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci U S A 2009; 106: 268\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFaps201791_CR32","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/gt.2012.42","volume":"20","author":"B Thaci","year":"2013","unstructured":"Thaci B, Ulasov IV, Ahmed AU, Ferguson SD, Han Y, Lesniak MS . Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation. Gene Ther 2013; 20: 318\u201327.","journal-title":"Gene Ther"},{"key":"BFaps201791_CR33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.59566\/IJBS.2012.8087","volume":"8","author":"XY Liu","year":"2012","unstructured":"Liu XY . The excellent anti-tumour strategy (CTGVT, OV-gene) and the excellent anti-tumor gene (IL-24). Int J Biomed Sci 2012; 8: 87\u201393.","journal-title":"Int J Biomed Sci"},{"key":"BFaps201791_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1477-7819-11-132","volume":"11","author":"LG Chen","year":"2013","unstructured":"Chen LG, Wang HJ, Yao HB, Guan TP, Wu F, He XJ, et al. GP73 is down-regulated in gastric cancer and associated with tumor differentiation. World J Surg Oncol 2013; 11: 132.","journal-title":"World J Surg Oncol"},{"key":"BFaps201791_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cell.2013.06.005","volume":"154","author":"CL Chaffer","year":"2013","unstructured":"Chaffer CL, Marjanovic ND, Lee T, Bell G, Kleer CG, Reinhardt F, et al. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 2013; 154: 61\u201374.","journal-title":"Cell"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201791.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201791","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/aps.2017.91","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/aps201791.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T19:38:41Z","timestamp":1719430721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,7]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["BFaps201791"],"URL":"https:\/\/doi.org\/10.1038\/aps.2017.91","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,7]]},"assertion":[{"value":"28 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}